BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12433264)

  • 1. Survival following a diagnosis of Alzheimer disease.
    Brookmeyer R; Corrada MM; Curriero FC; Kawas C
    Arch Neurol; 2002 Nov; 59(11):1764-7. PubMed ID: 12433264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy in Alzheimer's disease (AD).
    Zanetti O; Solerte SB; Cantoni F
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():237-43. PubMed ID: 19836639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after initial diagnosis of Alzheimer disease.
    Larson EB; Shadlen MF; Wang L; McCormick WC; Bowen JD; Teri L; Kukull WA
    Ann Intern Med; 2004 Apr; 140(7):501-9. PubMed ID: 15068977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.
    Helzner EP; Scarmeas N; Cosentino S; Tang MX; Schupf N; Stern Y
    Neurology; 2008 Nov; 71(19):1489-95. PubMed ID: 18981370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia and Alzheimer disease incidence: a prospective cohort study.
    Kukull WA; Higdon R; Bowen JD; McCormick WC; Teri L; Schellenberg GD; van Belle G; Jolley L; Larson EB
    Arch Neurol; 2002 Nov; 59(11):1737-46. PubMed ID: 12433261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional transitions and active life expectancy associated with Alzheimer disease.
    Dodge HH; Shen C; Pandav R; DeKosky ST; Ganguli M
    Arch Neurol; 2003 Feb; 60(2):253-9. PubMed ID: 12580712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease and mortality: a 15-year epidemiological study.
    Ganguli M; Dodge HH; Shen C; Pandav RS; DeKosky ST
    Arch Neurol; 2005 May; 62(5):779-84. PubMed ID: 15883266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
    Kawas C; Gray S; Brookmeyer R; Fozard J; Zonderman A
    Neurology; 2000 Jun; 54(11):2072-7. PubMed ID: 10851365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE genotype and survival in men and women with Alzheimer's disease.
    Dal Forno G; Carson KA; Brookmeyer R; Troncoso J; Kawas CH; Brandt J
    Neurology; 2002 Apr; 58(7):1045-50. PubMed ID: 11940690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of familial risk of Alzheimer disease across the late life span.
    Silverman JM; Ciresi G; Smith CJ; Marin DB; Schnaider-Beeri M
    Arch Gen Psychiatry; 2005 May; 62(5):565-73. PubMed ID: 15867110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.
    Zandi PP; Carlson MC; Plassman BL; Welsh-Bohmer KA; Mayer LS; Steffens DC; Breitner JC;
    JAMA; 2002 Nov; 288(17):2123-9. PubMed ID: 12413371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up.
    Wattmo C; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2014; 38(5-6):286-99. PubMed ID: 24992891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.
    Miech RA; Breitner JC; Zandi PP; Khachaturian AS; Anthony JC; Mayer L
    Neurology; 2002 Jan; 58(2):209-18. PubMed ID: 11805246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
    Agüero-Torres H; Fratiglioni L; Guo Z; Viitanen M; Winblad B
    J Am Geriatr Soc; 1998 Apr; 46(4):444-52. PubMed ID: 9560066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.
    Yasar S; Corrada M; Brookmeyer R; Kawas C
    Neurobiol Aging; 2005 Feb; 26(2):157-63. PubMed ID: 15582745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.
    Williams MM; Xiong C; Morris JC; Galvin JE
    Neurology; 2006 Dec; 67(11):1935-41. PubMed ID: 17159097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort.
    Doody R; Pavlik V; Massman P; Kenan M; Yeh S; Powell S; Cooke N; Dyer C; Demirovic J; Waring S; Chan W
    Dement Geriatr Cogn Disord; 2005; 20(2-3):198-208. PubMed ID: 16088145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study.
    Lönnroos E; Kyyrönen P; Bell JS; van der Cammen TJ; Hartikainen S
    J Alzheimers Dis; 2013; 33(1):157-64. PubMed ID: 22914589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.